跳至主要内容
临床试验/CTRI/2023/10/058501
CTRI/2023/10/058501招募中不适用

A randomized, double-blind, parallel group clinical study to evaluate efficacy and safety of UO ABG 01 in the management of borderline cardio vascular risk factors

Xtractiva Life Science Private Limited1 个研究点 分布在 1 个国家目标入组 56 人开始时间: 2023年10月20日最近更新:

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
56
试验地点
1
主要终点
• Serum triglycerides

研究概览

简要总结

Rapidly growing prevalenceof cardiovascular disease is a major threat for the developed as well asdeveloping world warranting urgent need of intervention. Complementary andalternative medicines are gaining popularity among general population becauseof their safety profile and easy administration. Garlic, in particular, isconsidered one of the best disease-preventive foods because of its potent andwidespread effects. This study is to find out the role of garlic in the management of borderline cardio vascularrisk factors.

研究设计

研究类型
Interventional
分配方式
Stratified block randomization
盲法
Participant and Investigator Blinded

入排标准

年龄范围
25.00 Year(s) 至 65.00 Year(s)(—)
性别
All

入选标准

  • Male or female subjects between 25 to 65 years of age Ability to understand the risks/benefits of the protocol Female subjects of childbearing potential must be using a medically acceptable form of birth control.
  • Female subjects of non-childbearing potential must be amenorrheic for at least 1 years or had a hysterectomy and/or bilateral oophorectomy Serum triglycerides > 115mg/dL and less than < 199 mg/dL If former smoker (previously smoked ≥10 cigarettes/day for at least 1 year, cessation for at least 6 months Willing to give written informed consent and willing to comply with trial protocol.

排除标准

  • 未提供

结局指标

主要结局

• Serum triglycerides

时间窗: Day -7, Day 28, Day 56 and Day 84

• Serum HDL

时间窗: Day -7, Day 28, Day 56 and Day 84

• Serum LDL

时间窗: Day -7, Day 28, Day 56 and Day 84

• Total Cholesterol

时间窗: Day -7, Day 28, Day 56 and Day 84

Change from Baseline to End of the study in

时间窗: Day -7, Day 28, Day 56 and Day 84

次要结局

  • Change from Baseline to End of the study in(• Blood Pressure)

研究者

发起方
Xtractiva Life Science Private Limited
申办方类型
Pharmaceutical industry-Indian

研究点 (1)

Loading locations...

相似试验